Cite
MLA Citation
John Mascarenhas et al.. “Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.” Leukemia & lymphoma, vol. 60, no. 5, 2019, pp. 1343–1345. http://access.bl.uk/ark:/81055/vdc_100081081089.0x000038
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
John Mascarenhas et al.. “Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.” Leukemia & lymphoma, vol. 60, no. 5, 2019, pp. 1343–1345. http://access.bl.uk/ark:/81055/vdc_100081081089.0x000038